H35.50
Unspecified hereditary retinal dystrophy
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified hereditary retinal dystrophy is a general term used to describe a group of genetic disorders that affect the retina, leading to progressive vision loss. The retina is a light-sensitive layer of tissue at the back of the eye that plays a crucial role in converting light into neural signals sent to the brain. When the retina is damaged or degenerates over time, it can result in blurred vision, loss of central or peripheral sight, and, in some cases, complete blindness. As the term 'unspecified' suggests, this diagnosis does not specify a particular subtype of retinal dystrophy, but rather indicates an inherited condition impacting retinal function.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from parents Familial transmission patterns suggest autosomal dominant, autosomal recessive, or X-linked inheritance Some cases may involve new mutations that are not inherited from parents
Key Symptoms: Gradual loss of visual acuity Difficulty seeing in low light or darkness Increased sensitivity to glare Loss of peripheral (side) vision Difficulty distinguishing colors Progressive deterioration of central vision in some types
Diagnostic & Treatment
Diagnosis Path: Diagnosis of unspecified hereditary retinal dystrophy typically involves a combination of clinical examinations and testing, including: - Comprehensive eye examination to assess visual acuity and fundus appearance - Electroretinography (ERG) to evaluate retinal electrical responses - Optical coherence tomography (OCT) to visualize retinal layers - Genetic testing to identify specific gene mutations Because the condition is broad and can resemble other retinal disorders, the diagnosis often involves ruling out other causes of vision loss.
Treatment Protocols: Currently, there are limited options for reversing retinal dystrophy. Management focuses on slowing progression and maximizing remaining vision, including: - Regular monitoring by eye care professionals - Use of low vision aids and devices to support daily activities - Genetic counseling for affected individuals and families - Investigational treatments and clinical trials may be available for specific subtypes of retinal dystrophy - Maintaining overall eye health through proper nutrition and protection from bright lights and UV exposure Research into gene therapies and regenerative treatments is ongoing, offering hope for future interventions.
Clinical Advice & FAQs
Billing Guidance
Is H35.50 a billable ICD-10 code?
Yes, H35.50 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.50?
Clinical documentation must specify the nature of Unspecified hereditary retinal dystrophy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference